Pulmokine Receives $1,000,000 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e5fa8fa6-23b7-478f-89a5-24fc190e4bd8 - Date
3/5/2015 - Company Name
Pulmokine - Mailing Address
7 University Place Rensselaer, NY 12144 USA - Company Description
Pulmokine is a privately held biopharmaceutical company. Our focus is on pulmonary disease and kinase inhibitor technology, hence our name Pulmokine. - Website
http://www.pulmokine.net - Transaction Type
Venture Equity - Transaction Amount
$1,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. - M&A Terms
- Venture Investor
